Guanfacine is a prescription tablet that lowers blood pressure and, in an extended-release form, treats ADHD. It belongs to a drug class called selective alpha-2A adrenergic agonists. It is not a stimulant, and it is not a controlled substance. United States labeling for the plain tablet covers the management of high blood pressure in adults.
That split personality is the single most confusing thing about this medicine. One version of the same molecule sits in the cardiology aisle. Another version, released slowly over the day, is approved for attention deficit hyperactivity disorder in children and teenagers. Same active ingredient, different products, different labels, different reasons to take it.
This page explains what the official labeling says in everyday words, what side effects patients report most often, which interactions matter, and what actually drives the monthly self-pay cost. It is a reference page, not a prescription. Your clinician decides what fits your history.
How guanfacine works: blood vessels and the prefrontal cortex
The medicine acts on alpha-2A receptors, which sit on nerve cells that regulate the body’s fight-or-flight signaling. When those receptors are switched on, the brain sends fewer sympathetic signals outward. Blood vessels relax, heart rate eases, and blood pressure falls. Patient-facing drug references describe the blood pressure effect in similar plain terms, as in the MedlinePlus entry for this tablet.
The ADHD story involves the same receptors in a different place. Laboratory work suggests the drug strengthens signaling in the prefrontal cortex, the part of the brain that holds attention, filters distraction and pauses before acting. Researchers who study this mechanism describe it as improving the strength of prefrontal network connections rather than pushing the brain harder, an argument laid out in a published review of guanfacine’s mechanism of action.
That distinction matters for expectations. Stimulants increase dopamine and norepinephrine signaling and often work within hours. An alpha-2A agonist works differently, and the effect on attention or irritability tends to build gradually over weeks. Nobody can promise a result, and response varies widely between people.
Approved uses, and where ADHD fits
The immediate-release tablet is labeled for managing hypertension. Labeling notes it can be used alone or alongside other blood pressure medicines, especially thiazide-type diuretics. It is not usually the first medicine tried for high blood pressure, and most treatment guidelines place other classes ahead of it.
The extended-release product is a separate approval. Its FDA label covers ADHD in patients aged 6 to 17, both on its own and added to a stimulant when a stimulant alone is not enough. The details, including the population studied, appear in the FDA prescribing information for the extended-release tablet. A pharmacy review of the product’s approval history covers the same ground in a peer-reviewed summary of extended-release guanfacine.
Adults with ADHD
Search interest in guanfacine for ADHD in adults is heavy, so it is worth being exact. The ADHD approval is written for children and adolescents. Prescribing it to an adult for attention symptoms is off-label use, which is legal and common in psychiatry but means the label does not carry adult efficacy data for that purpose. Adults are sometimes offered it when stimulants caused problems, when a controlled substance is not appropriate, or when anxiety and irritability sit alongside inattention. General background on ADHD treatment options is available from the National Institute of Mental Health topic page.
Autism, tics and other off-label questions
The medicine has been studied for hyperactivity and impulsivity in children with autism spectrum disorder, and for tic disorders. Some trials reported benefit for hyperactivity. None of that adds an approved indication, and the evidence base is smaller than the ADHD data. If you want to read the primary literature, start with published trials indexed on PubMed for autism. Treat any off-label plan as a conversation about tradeoffs, not a settled answer.
How it compares with a stimulant
Guanfacine and amphetamine products such as Adderall are not the same thing and are not interchangeable. Amphetamine salts are stimulants and Schedule II controlled substances. This alpha-2A agonist is neither. It is more likely to cause sleepiness than sleeplessness, and it does not carry stimulant-style appetite suppression or the same misuse potential. It also does not work as quickly. Which approach suits a person depends on symptoms, heart and blood pressure history, sleep, other medicines and prior response. That is a clinician’s call.
Immediate-release, extended-release, and the brand names
Four terms cover almost every question about forms. The generic name is guanfacine, usually dispensed as guanfacine hydrochloride. Tenex was the original brand for the immediate-release tablet used in high blood pressure. Intuniv is the brand for the extended-release tablet approved for ADHD. Generic versions of both forms are widely available in US pharmacies.
Immediate-Release vs Extended-Release Guanfacine
| Immediate-Release (Tenex) | Extended-Release (Intuniv) | |
|---|---|---|
| Approved use | Hypertension in adults | ADHD in ages 6-17 |
| Generic available | Yes | Yes |
| Tablet handling | Standard | Swallow whole; no crushing, chewing, or splitting |
| Food interaction | Not specified | Avoid high-fat meals |
| Controlled substance | No | No |
The two release forms are not swapped one milligram for one milligram. The extended-release product releases drug slowly, so blood levels behave differently, and labeling specifically warns against substituting it for the immediate-release tablet on a milligram-per-milligram basis. That is a safety point, not a technicality.
Two more handling rules come straight from the extended-release labeling. The tablets are swallowed whole, not crushed, chewed or split, because breaking them can release the dose too fast. And they should not be taken with a high-fat meal, which raises how much drug the body absorbs. Timing and dose belong to your prescriber and the label, so follow the instructions on your own bottle rather than a general article.
On brand versus generic, FDA-approved generics must meet bioequivalence standards, and for extended-release products the release profile is part of that. Some patients still report feeling a difference after a switch. If that happens, note what changed and when, and tell the prescribing clinician instead of adjusting anything yourself.
Side effects most people notice first
The common effects follow logically from what the drug does. It calms sympathetic signaling, so it tends to make people drowsy and slightly lower their blood pressure and heart rate. Frequently reported effects across the labeling and standard drug references include:
- Sleepiness, sedation or daytime tiredness, often strongest early on
- Dry mouth
- Dizziness or lightheadedness, especially when standing up quickly
- Headache
- Low blood pressure and a slower pulse
- Abdominal pain, nausea or constipation
- Irritability, low mood or unusual fatigue
- Trouble sleeping in some patients, despite the sedating reputation
A patient-facing summary of these effects, including the driving and alertness caution, is set out in Mayo Clinic’s oral route drug description. Fainting is less common but real, and it is one of the reasons clinicians ask about dizziness at follow-up.
Does the sedation ease? For many people the drowsiness is worst in the first days to weeks and softens as the body adjusts, particularly if the dose is raised slowly. That is a general pattern, not a guarantee, and some patients stay too sleepy to continue. Nothing here should be read as a reason to push through symptoms that feel unsafe.
Get urgent care for fainting, chest pain, a very slow or irregular heartbeat, severe confusion, signs of an allergic reaction such as swelling of the face or throat, or new thoughts of self-harm. Those are emergency-room questions, not wait-and-see questions.
Warnings, contraindications and stopping safely
The labeled contraindication is short: do not take it if you have had a hypersensitivity reaction to guanfacine or to any ingredient in the product. Almost everything else is a warning or precaution, which means it calls for care and monitoring rather than an automatic no.
The warnings worth knowing in plain English:
- Low blood pressure, slow heart rate and fainting. Risk rises when the drug is combined with other blood pressure medicines or when a person is dehydrated.
- Sedation. Labeling advises caution with driving, machinery and other tasks needing alertness until you know how the medicine affects you.
- Rebound high blood pressure after abrupt stopping. Suddenly quitting a centrally acting blood pressure medicine can send blood pressure and heart rate up sharply, sometimes with nervousness or headache. Doses are normally reduced gradually under supervision.
- Existing heart, kidney or liver conditions. A history of fainting, heart block, low blood pressure, or reduced kidney or liver function changes how carefully this drug is used.
- Pregnancy and breastfeeding. Human data are limited, so this belongs in a direct conversation with your clinician rather than in a general guide.
Because both blood pressure and pulse can drift down, home readings are often part of follow-up, especially in the first weeks and after any change. Averaging several readings is more informative than reacting to one number.
Blood pressure average
Programmes that screen on blood pressure want an average of several readings, not the one that worried you.
Take readings seated, arm supported, after five minutes rest. A single high reading is rarely the point; the pattern is.
For blood pressure treatment context beyond a single drug, the American Heart Association keeps a plain-language hub on high blood pressure.
Interactions that change how much drug you get
Guanfacine is processed largely by a liver enzyme called CYP3A4. That single fact explains most of its interaction list. Medicines and foods that block that enzyme can raise drug levels, which usually means more sedation, more dizziness and lower blood pressure. Medicines that speed the enzyme up can lower levels, which can blunt the effect.
Categories to raise with a clinician or pharmacist:
- Strong CYP3A4 inhibitors such as certain antifungals and some antibiotics, plus grapefruit juice, which can increase exposure to the extended-release form
- CYP3A4 inducers such as rifampin and some seizure medicines, which can reduce exposure
- Other blood pressure medicines, where the combined effect on pressure and pulse can be additive
- Sedating drugs and alcohol, including benzodiazepines, opioids, sleep aids, antihistamines and cannabis
- Valproic acid, where levels of the seizure medicine may rise
Full interaction detail, including the dosing adjustments labeling suggests when a strong inhibitor or inducer is unavoidable, is published in the current package inserts collected on the DailyMed label database for this molecule. Bring a complete list of everything you take, including supplements, to the first visit. Interaction screening only works on information the prescriber actually has.
What guanfacine costs without insurance
Two separate costs sit on this page, and mixing them is how people end up surprised. One is the medication itself at a pharmacy. The other is the telehealth program fee, meaning what a platform charges for the visit, the prescription and any follow-up. Cash pay and insurance are tracked separately here, and plan fees never include your copays or deductible, which vary by plan and state.
On the medication side, four things move the number:
- Generic or brand. Generic guanfacine tablets are long established. Brand-name products typically cost considerably more than their generic equivalents.
- Immediate-release or extended-release. Extended-release formulations generally carry a higher price than plain tablets of the same molecule.
- Pharmacy and dispensing quantity. Cash prices for the same generic can differ noticeably between pharmacies in one zip code, and a 90 day fill often costs less per month than a 30 day fill.
- Dose strength. Different strengths are priced differently, so a dose change can change the bill.
For the program side, the lowest recurring self-pay monthly figure tracked across programs prescribing this medication appears here: . Advertised prices move often, so treat any figure as a snapshot and check what a plan actually includes: the visit, refills, messaging, dose changes, and whether the medication is billed separately. Intro pricing that jumps at renewal is common enough to ask about directly.
Thinking in months hides the real number. Annual math is usually the more honest way to compare a cheap medicine with a recurring program fee.
What a year actually costs
Programmes quote a monthly headline. Add the medication, the labs and the renewal price and the real number is usually different.
Advertised prices change often and intro pricing rarely lasts. Ask what the renewal rate is before you commit to a plan.
If you want to see how one month of a treatment plan is broken out before committing, the Free Savings Report shows the format, and the other Health Calculators cover cost and cash versus insurance comparisons. For coverage and drug-cost policy background, KFF publishes independent research on prescription costs.
How telehealth programs prescribe it, and what varies
One practical detail shapes remote care here: this medicine is not a controlled substance. Stimulant ADHD medicines are, and federal rules around remote prescribing of controlled substances have shifted repeatedly. Non-stimulant options like this one sit outside those specific restrictions, which is part of why online programs offer them. State telemedicine and licensing rules still apply, and the prescriber must be licensed where you are located.
What differs from one program to another:
- Assessment depth. Some programs run a structured ADHD evaluation or require records; others run a shorter intake.
- Who prescribes. Psychiatrist, psychiatric nurse practitioner, or a general clinician, and whether you see the same person again.
- Monitoring. Blood pressure and pulse checks, whether a home cuff is expected, and how dose changes are handled between visits.
- Cardiac and history screening, including fainting history and other blood pressure medicines.
- Pharmacy routing. Whether the prescription goes to your local pharmacy or a mail partner, and who pays for shipping.
- Therapy and coaching, which some ADHD programs bundle and others do not.
- Insurance. Whether the program can bill your plan at all, or is cash pay only.
You can compare programs that treat these conditions in the Telehealth Provider Directory, read how each dimension is weighted on the Scoring Methodology page, and browse related molecules through the Medication Reference Index. Ongoing coverage of pricing and access sits in our Telehealth Reporting.
Questions to ask, and when to call for help
Going in with a short list makes a 15 minute visit far more useful. Worth asking:
Questions to Ask Before Starting Guanfacine
- Are you prescribing immediate-release or extended-release, and why?
- Is this use on-label for my age and condition?
- How slowly will the dose be raised?
- What blood pressure and pulse readings should prompt a call?
- Which of my current medicines or supplements interact with this?
- What is the plan if daytime sleepiness becomes unsafe?
- How do we taper if I stop, and what if I miss doses?
- What does the monthly cost include versus what is billed separately?
- Are you prescribing the immediate-release or extended-release form, and why that one?
- Is this for blood pressure, ADHD symptoms, or both, and is that use on-label for me?
- How slowly will the dose be raised, and when should I expect to judge whether it helps?
- What blood pressure and pulse readings should prompt a call?
- Which of my current medicines and supplements interact with this?
- What is the plan if daytime sleepiness makes work or school unsafe?
- How do we taper if I stop, and what happens if I miss doses or run out?
- What does the monthly cost include, and what is billed separately at the pharmacy?
Seek prompt medical help for fainting or near-fainting, chest pain, a heartbeat that feels very slow or irregular, severe dizziness that does not settle, breathing trouble or facial swelling, or any new thoughts of harming yourself. Call your prescriber, not a search engine, before stopping a blood pressure medicine on your own, because abrupt discontinuation carries its own risk. If a child or teenager becomes unusually withdrawn, tearful or agitated after starting, report it early rather than waiting for the next scheduled visit.
Authoritative sources
- FDA prescribing information, extended-release tablets
- DailyMed current package labeling
- MedlinePlus patient drug information
Educational content, not medical advice. Always consult a qualified clinician before starting, stopping or switching treatment.
